Charity warns on adrenaline injector expiry

Patients at risk of anaphylaxis should check their adrenaline injectors have not passed their expiry date, the Anaphylaxis Campaign charity has warned.

UK patients are being encouraged to check the expiry dates on their adrenaline injectors (Photograph: SPL)

Around 250,000 adrenaline injectors will expire in December and January. Currently, 210,000 patients in the UK are prescribed adrenaline injectors.

The Anaphylaxis Campaign is encouraging patients to 'check and carry' - to check the device has not expired and carry it at all times.

The campaign is being supported by ALK-Abello, the manufacturer of the Epipen adrenaline injector. Research has shown that around a third of people prescribed adrenaline injectors are likely to have an out-of-date device, the company said.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Just published

Person selecting medicine in a dispensary

Dispensing GPs demand funding overhaul to ensure services remain viable

Dispensing doctors have demanded improved representation in GP contract negotiations,...

GP consultation room

GPs seeing cases of malnutrition and rickets as cost-of-living crisis hits patient health

Three quarters of GPs are seeing a rise in patients with problems linked to the cost-of-living...

Female GP listening to a patient

What GPs need to know about changes to Good Medical Practice

Dr Udvitha Nandasoma, the MDU’s head of advisory services, explains what GPs need...

Dr Caroline Fryar

Viewpoint: Doctors should be given protected time to digest Good Medical Practice

There's a lot for doctors to digest in the GMC's Good Medical Practice update before...

MIMS Learning Clinical Update podcast

MIMS Learning Clinical Update podcast explores the ‘defining issue of our age’

The latest episode of the MIMS Learning Clinical Update podcast features an interview...


NICE moves CVD advice closer to QOF and updates treatment escalation options

NICE draft guidance on cardiovascular disease backs a new target for lipid levels...